Clinical TrialsSearch results
Number of results: 2579
Recruiting
- [M24-311]Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab
- unresectable metastatic colorectal cancer
- Yamagishi Chika
- 2023-11-10
Recruiting
- [M24-427]ABBV-400 in Select Advanced Solid Tumor Indications
- HCC, PDAC, BTC, ESCC, BC, HNSCC
- Yamagishi Chika
- 2023-12-25
Recruiting
- 24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up
- Chronic Spontaneous Urticaria
- Maruyama Hideki
- 2024-03-06
Recruiting
- 64Cu-NCAB001 in patients with pancreatic cancer
- Pancreatic cancer without clinically distant metastasis
- Hijioka Susumu
- 2023-08-29
Recruiting
- A 1.5% levofloxacin otic solution (ComplexTM) post-marketing study in patients with otitis externa
- Otitis externa including myringitis caused by bacteria without otitis media
- Tomohiro Haga
- 2024-06-19
Recruiting
- A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2)
- refractory chronic cough
- Kawamoto Mika
- 2024-02-01
Recruiting
- A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Vitiligo (Active and Stable)
- Vitiligo
- Kawai Norisuke
- 2022-12-23
Recruiting
- A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
- Vitiligo
- Kawai Norisuke
- 2024-02-27
Recruiting
- A Basket Long-term Extension Study of Ustekinumab in Pediatric Participants
- Crohn Disease, Ulcerative Colitis, Psoriatic Arthritis
- Nishikawa Kazuko
- 2022-07-06
Recruiting
- A C5 inhibitor-controlled Study to Evaluate the Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) who are Complement Inhibitor Treatment-Naive or Have Not Recently Received Complement Inhibitor Therapy
- Paroxysmal Nocturnal Hemoglobinuria
- Aurand Lisa
- 2022-11-05